Kraig Biocraft Laboratories Successfully Completes Recombinant Cocoon Production From Spring Trials
ANN ARBOR, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today what it considers to be a major milestone.
- ANN ARBOR, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today what it considers to be a major milestone.
- The Company has completed rearing of the first generation of its new BAM-1 parental strains as part of its spring production trial.
- Kraig Labs has successfully produced cocoon at rates that exceeded all expectations and control parameters for these trials.
- Each parental strain was divided into two batches, creating a total of four separate production trial groups.